HNR1:XETRHannover Rueck SE Analysis

Hannover Rück is trading at €229.4, well beneath its 20‑day (€232.1), 50‑day (€248.8) and 200‑day (€251.8) moving averages, signalling a bearish price backdrop. Technical momentum, however, shows a bullish MACD histogram (+1.16) and a neutral‑to‑slightly‑oversold RSI (40), hinting at a possible short‑term rebound toward the support zone around €223.4. The stock’s beta of 0.11 indicates minimal market‑wide volatility, yet its 30‑day volatility of 24% and a decreasing volume trend raise concerns about price stability. Fundamentally, the company appears cheap with a trailing P/E of 9.6 versus an industry average of 17.1, a solid ROE of 21.7% and a healthy cash position, while revenue has contracted 22.8% YoY. Analyst sentiment is positive (15 analysts, “buy” rating, median target €275), and the DCF model suggests a fair value of €436, implying roughly 24% upside. No dividend is paid, so income‑focused investors will find the stock unattractive on that front. Overall, the blend of valuation attractiveness, strong profitability metrics, and low systematic risk makes HNR1 a compelling candidate for value‑oriented investors despite short‑term price weakness.
The primary risks stem from elevated short‑term volatility, a declining revenue trend, and potential regulatory headwinds in the reinsurance sector. Liquidity concerns arise from a volume profile that is markedly below its 10‑day and 3‑month averages, which could amplify price swings on new market activity. Nonetheless, the company’s robust capital base, low debt‑to‑equity ratio, and diversified geographic exposure help mitigate broader sector and currency risks, supporting a cautiously optimistic outlook.